Treatment with CDDO-Im significantly decreased the number of CD44+/CD24−/low/EpCAM+ cells in sphere culture (Fig. 3B), suggesting that CDDO-Im could be used as a potential agent to target cancer stem cells in triple negative breast cancer. The gene discussed is CD24; the disease is triple-negative breast carcinoma.